These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7711000)

  • 1. Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.
    Prell GD; Green JP; Kaufmann CA; Khandelwal JK; Morrishow AM; Kirch DG; Linnoila M; Wyatt RJ
    Schizophr Res; 1995 Jan; 14(2):93-104. PubMed ID: 7711000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans.
    Prell GD; Khandelwal JK; Burns RS; LeWitt PA; Green JP
    Compr Gerontol A; 1988 Oct; 2(3):114-9. PubMed ID: 2906817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine metabolites in cerebrospinal fluid of the rhesus monkey (Macaca mulatta): cisternal-lumbar concentration gradients.
    Prell GD; Khandelwal JK; Burns RS; Green JP
    J Neurochem; 1988 Apr; 50(4):1194-9. PubMed ID: 3258017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
    Prell GD; Green JP; Elkashef AM; Khandelwal JK; Linnoila M; Wyatt RJ; Lawson WB; Jaeger AC; Kaufmann CA; Kirch DG
    Schizophr Res; 1996 May; 19(2-3):171-6. PubMed ID: 8789915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rostral-caudal concentration gradients of histamine metabolites in human cerebrospinal fluid.
    Prell GD; Khandelwal JK; LeWitt PA; Green JP
    Agents Actions; 1989 Mar; 26(3-4):267-72. PubMed ID: 2735222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal fluctuation in levels of histamine metabolites in cerebrospinal fluid of rhesus monkey.
    Prell GD; Khandelwal JK; Burns RS; Green JP
    Agents Actions; 1989 Mar; 26(3-4):279-86. PubMed ID: 2735223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid.
    Prell GD; Khandelwal JK; Burns RS; LeWitt PA; Green JP
    Arch Gerontol Geriatr; 1991; 12(1):1-12. PubMed ID: 15374459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid.
    Prell GD; Khandelwal JK; Burns RS; LeWitt PA; Green JP
    Arch Gerontol Geriatr; 1990; 11(1):85-95. PubMed ID: 15374496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
    Jeste DV; Doongaji DR; Linnoila M
    Br J Psychiatry; 1984 Feb; 144():177-80. PubMed ID: 6200172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pros-Methylimidazoleacetic acid in cerebrospinal fluid of patients with chronic schizophrenia: relationships to ratings of symptoms, ventricular brain ratios, and rates of urine excretion.
    Prell GD; Green JP; Khandelwal JK; Wyatt RJ; Lawson WB; Jaeger AC; Kaufmann CA; Kirch DG
    Clin Neuropharmacol; 1996 Oct; 19(5):415-9. PubMed ID: 8889284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.
    van Kammen DP; Peters J; Yao J; van Kammen WB; Neylan T; Shaw D; Linnoila M
    Arch Gen Psychiatry; 1990 Feb; 47(2):161-8. PubMed ID: 1689140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: II. Correlations with psychopathology.
    Issa F; Kirch DG; Gerhardt GA; Bartko JJ; Suddath RL; Freedman R; Wyatt RJ
    Psychiatry Res; 1994 Jun; 52(3):251-8. PubMed ID: 7991719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D; Breier A; Hsiao JK; Doran AR; Wolkowitz OM; Pato CN; Konicki PE; Potter WZ
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of histamine metabolites in brain and cerebrospinal fluid provides insights into histaminergic activity.
    Prell GD; Green JP
    Agents Actions; 1994 Jun; 41 Spec No():C5-8. PubMed ID: 7976804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of tele-methylhistamine and histamine in human cerebrospinal fluid, urine, and plasma.
    Khandelwal JK; Hough LB; Morrishow AM; Green JP
    Agents Actions; 1982 Dec; 12(5-6):583-90. PubMed ID: 7164933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid.
    Prell GD; Green JP
    Agents Actions Suppl; 1991; 33():343-63. PubMed ID: 1828934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
    Saito T; Ishizawa H; Tsuchiya F; Ozawa H; Takahata N
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):189-94. PubMed ID: 2431183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses.
    Issa F; Gerhardt GA; Bartko JJ; Suddath RL; Lynch M; Gamache PH; Freedman R; Wyatt RJ; Kirch DG
    Psychiatry Res; 1994 Jun; 52(3):237-49. PubMed ID: 7991718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.